Drug Therapy in the Elderly

Slides:



Advertisements
Similar presentations
Medication Reduction in Persons with Dementia Medical Staff Education.
Advertisements

Connecting Pharmacology with Therapeutics Clive Roberts.
Introduction Medication non adherence ( noncompliance) remains a major problem. You have to assess and treat adherence related problems that can adversely.
© 2007 Thomson - Wadsworth Chapter 13 Nutrition Care and Assessment.
Principles of Drug Use in the Elderly Alastair Stephens Sophie Rozwadowski.
{ ADVERSE DRUG REACTIONS To ensure patient, family/caregiver and home health personnel are instructed to identify adverse reactions to medications and.
Medication Regimen Review Guidance Training CFR § (c)(1)(2) F428.
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 04- The Nursing Process.
Polypharmacy of Older Adults
Introduction to Pharmacology. Overview Pharmaceutics Pharmacokinetics Pharmacodynamics.
UMMS CRIT Module II: Drug Therapy in the Elderly Jerry H. Gurwitz, MD Chief, Division of Geriatric Medicine University of Massachusetts Medical School.
Pharmacotherapy in the Elderly Paola S. Timiras May, 2007.
Pharmacotherapy in the Elderly Judy Wong
Dr AZZA ELSHERBINY Assistant professor of pharmacology.
Patient Compliance With Medical Advice. Patient compliance (patient adherence) :  The extent to which the patient adheres to medical advice Patient compliance.
Readmission and Chronic illness that could benefit from end of life discussions.
Chapter 3. PHARMACODYNAMICS  Definition: The study of the impact of drugs on the body  Primary focus are the mechanisms by which drugs exert their therapeutic.
Includes adults >65 years old Fastest growing population in US and in the majority of developed nations. 20% of hospitalizations for those >65 are due.
Pharmacology in the Elderly. Pharmacological Challenges in the Elderly  Pharmacokinetic changes  Pharmacodynamic changes  Multiple co-morbidities 
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 25 Drug Interactions.
Yasar Kucukardali Professor, Internal Medicine Yeditepe University.
How and Why Drugs Work Chapter 5
Factors Affecting Drug Activity Chapter 11 Pages
Treating Depression in the Elderly A Multi-disciplinary Approach 12/11/2003.
POLYPHARMACY Pio L. Oliverio, MD Fellow, Geriatrics SVCMC, Jamaica, NY
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 11 Drug Therapy in Geriatric Patients.
Food-Drug Interactions Chapter 19. © 2004, 2002 Elsevier Inc. All rights reserved. Key Terms n Bioavailability: degree to which a drug or other substance.
 Pharmacology- Study of science that deals with the study of therapeutic agents  Pharmacodynamics- study of the action of drugs on living tissue  Pharmacy-
Chapter 35 Safe Medication Use. Drugs Commonly Used by Older Adults Cardiovascular agents Antihypertensives Analgesics Antiarthritic agents Sedatives.
Caring for Older Adults Holistically, 4th Edition Chapter Nineteen Pharmacology and Its Significance for Older Adults.
Clinical Pharmacy Part 2
© 2012 The McGraw-Hill Companies, Inc. All rights reserved. 1 Pharmacology: An Introduction CHAPTER.
Introduction to Pharmacology PHARM TECH. Pharmacology  Pharmacology is the science that deals with the study of therapeutic (beneficial) agents.  Knowledge.
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 16Psychopharmacology.
Chapter 29 Medication Administration
Problems of Polypharmacy
Orientation to Pharmacology
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 8 Individual Variation in Drug Responses.
Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction or distribution without the prior written consent of McGraw-Hill Education.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 2 Application of Pharmacology in Nursing Practice.
Polypharmacy May 2008 CRIT Heidi Auerbach, MD Copyright Boston University Medical Center.
Copyright © 2011 Delmar, Cengage Learning. ALL RIGHTS RESERVED. Chapter 30 Medication Administration.
Managing Exercise in Persons with Multiple Chronic Conditions Chapter 04.
Age Changes By Sue Henderson.
Introduction.
Age Changes By Sue Henderson. Pharmacokinetics How body acts on drug: Reduced renal function, resulting in reduced elimination of renally excreted drugs.
Effects of Medication. Side Effects -- unintended or secondary effects 1. May not be harmful 2. May permit the drug to be used for a secondary purpose.
Introduction to Pharmacology Yacoub Irshaid MD, PhD, ABCP Department of Pharmacology.
1 Biopharmaceutics Dr Mohammad Issa Saleh. 2 Biopharmaceutics Biopharmaceutics is the science that examines this interrelationship of the physicochemical.
Principles of Pharmacology Brenda Rowe, RN, MN, JD.
Pharmacogenomics: Improving the Dynamic of Care in Medication Management 1.
Copyright © 2016 by Elsevier, Inc. All rights reserved. Geropharmacology.
Pharmacy Health Information Technology Collaborative Presenter: Shelly Spiro RPh, FASCP Pharmacy HIT Collaborative, Executive Director.
Aging, Health and Mental Health Prepared for distribution by the CSWE Gero-Ed Center.
Meet & Greet. Welcome Objectives: 1. Review the core terminology used in pharmacology. 2. Discuss the features of the “perfect” drug. 3. Examine the.
Jacqueline Dunbar-Jacob, PhD, RN, FAAN Dean, School of Nursing University of Pittsburgh School of Nursing Center for Research in Chronic Disorders.
Integrative Approaches to Pharmacotherapy—A Look at Complex Cases
Factors Affecting Drug Activity
Drug Therapy in Geriatric Patients
Effects of Medication Therapeutic Effects=Desired or intended effects of medication – refers to the primary purpose of prescribing and administrating medication.
Chapter Eleven: Management of Chronic Illness
Drug Actions and Interactions
What’s New in Medication Management: Focus on Older Adults and Caregivers Tuesday, April 30, :00 Noon CDT Mike Varnell, RPh, CSA (214)
Biopharmaceutics Dr Mohammad Issa Saleh.
Orientation to Pharmacology
Common Health Problems of Older Adults
Principles of Pharmacology
Introduction to Pharmacogenetics
Introduction to Clinical Pharmacology Chapter 4 The Nursing Process
POLYPHARMACY.
Presentation transcript:

Drug Therapy in the Elderly Chapter 6 Drug Therapy in the Elderly

Chapter Outline: Pharmacodynamic Changes Introduction Polypharmacy Adverse Drug Reactions Noncompliance Causes of noncompliance Medication Management Introduction Pharmacokinetic Changes Absorption Distribution Metabolism Excretion

Pharmacokinetic Changes Pharmacokinetics is the study of how drugs travel through the body over time. It deals with all aspects of drug disposition in the body, including absorption from the administration site, distribution into various body compartments, hepatic metabolism to active & inactive metabolites, & excretion of parent drug & metabolites from the body.

Pharmacodynamic Changes: Pharmacodynamics refers to the action of drugs, or the biological effects resulting from the interaction between drugs & its receptor site. Age-related pharmacodynamic changes in the elderly can greatly influence drug response, usually leading to increased sensitivity or an exaggerated pharmacological response to a given drug.

Pharmacokinetic Parameter Absorption Distribution Metabolism Excretion

Polypharmacy: Polypharmacy refers to the use of multiple medications in one individual. They may be needed but the term polypharmacy usually connotes the use of more drugs than are needed.

Polypharmacy: As the number of medications taken increases, the likelihood of adverse drug reactions & drug-drug interactions also increases. As the complexity of the drug regimen increases, the risk of noncompliance increases.

Reasons for Polypharmacy:  number of chronic illnesses or physical ailments; a lack of one primary health provider to coordinate medical care & drug use, subsequent use of multiple physicians (specialists), use of multiple pharmacies, & self-treatment, primarily with over-the-counter drugs. Elderly take an average of 2.8 drugs per day Nursing homes=3.4 /day;hospitalized=9/day

Adverse Drug Reactions: Any unexpected, unintended, undesired, or excessive response to a drug when it is used in the approved manner. They typically: Require a modification in drug therapy (drug discontinuation or dosage change) Cause or prolong admission to the hospital Require supportive treatment Negatively affect prognosis & may result in disability or death.

Adverse Drug Reaction Risk Factors: An increased number of chronic illnesses. Severity of illnesses Pharmacokinetic changes Pharmacodynamic changes Polypharmacy

Observed Drug Reactions: Delirium Confusion Lethargy Fatigue Arrhythmias Nausea, vomiting Incontinence Tremor Tardive dyskinesia Pseudoparkinsonism Visual/hearing disturbances Hypotension Syncopal attacks,falls Constipation,diarrhea Electrolyte abnormalities Urinary retention

Noncompliance: Medication compliance has been defined as the extent to which a patient’s behavior coincides with a prescriber’s planned medical regimen. Any deviation from this is, obviously, noncompliance. 1.8 billion prescriptions written each year are taken incorrectly. Up to 90% is due to patients taking too little medication.

Factors associated-poor compliance: Female gender Low socioeconomic status Solitary living Lack of a support person Cognitive impairment Drug costs Multiple disease states Physical disabilities Complex drug regimens Polypharmacy Poor communication

Causes of Noncompliance: Polypharmacy & Complex Drug Regimens Physical Disabilities Poor Communication Cognitive Impairment Drug Costs

Medication Management: With every new complaint or symptom the drug regimen should be reviewed to identify any adverse drug reactions or rule out drug toxicity. Adverse reactions are often completely reversible-when source removed.

Drug Therapy in the Elderly: Offers tremendous benefits to elderly people when used appropriately. Periodic review of medication regimens must be done, so that elderly patients receive maximal benefits from drug therapy while minimizing potential adverse outcomes.